Alternative Energy Cybin receives FDA approval for new in-human clinical trial Patient enlistment for new study to treat Major Depressive Disorder set to begin promptly Rowan DunneJune 28, 2022
Analysis Field Trip white paper makes strong health and business case for ketamine therapy With solid efficacy and low cost, the popular club drug could help curb the personal toll and multi-billion dollar cost of North America's battle... Natalia Buendia CalvilloFebruary 9, 2021